de Campos Azevedo Clara Isabel, Ângelo Ana Catarina Leiria Pires Gago, Vinga Susana
Centro Hospitalar de Lisboa Ocidental, Lisbon, Portugal.
Hospital dos SAMS, Lisbon, Portugal.
Orthop J Sports Med. 2018 Nov 27;6(11):2325967118808242. doi: 10.1177/2325967118808242. eCollection 2018 Nov.
Painful dysfunctional shoulders with irreparable rotator cuff tears (IRCTs) in active patients are a challenge. Arthroscopic superior capsular reconstruction (ASCR) is a new treatment option originally described using a fascia lata autograft harvested through an open approach. However, concerns about donor site morbidity have discouraged surgeons from using this type of graft.
ASCR using a minimally invasive harvested fascia lata autograft produces good 6-month and 2-year shoulder outcomes in IRCTs, with low-impact thigh morbidity at 2 years.
Case series; Level of evidence, 4.
From 2015 to 2016, a total of 22 consecutive patients (mean age, 64.8 ± 8.6 years) with chronic IRCTs (Hamada grade 1-2; Goutallier cumulative grade ≥3; Patte stage 1: 2 patients; Patte stage 2: 6 patients; Patte stage 3: 14 patients) underwent ASCR using a minimally invasive harvested fascia lata autograft. All patients completed preoperative and 6-month evaluations consisting of the Simple Shoulder Test (SST), subjective shoulder value (SSV), Constant score (CS), range of motion (ROM), acromiohumeral interval (AHI), and magnetic resonance imaging. Twenty-one patients completed the 2-year shoulder and donor site morbidity assessments.
The mean active ROMs improved significantly ( < .001): elevation, from 74.8° ± 55.5° to 104.5° ± 41.9° (6 months) and 143.8° ± 31.7° (2 years); abduction, from 53.2° ± 43.3° to 86.6° ± 32.9° (6 months) and 120.7° ± 37.7° (2 years); external rotation, from 13.2° ± 18.4° to 27.0° ± 16.1° (6 months) and 35.6° ± 17.3° (2 years); and internal rotation, from 1.2 ± 1.5 points to 2.6 ± 1.5 points (6 months) and 3.8 ± 1.2 points (2 years). The mean functional shoulder scores improved significantly ( < .001): SST, from 2.1 ± 2.9 to 6.8 ± 3.5 (6 months) and 8.6 ± 3.5 (2 years); SSV, from 33.0% ± 17.4% to 55.7% ± 25.6% (6 months) and 70.0% ± 23.0% (2 years); CS, from 17.5 ± 13.4 to 42.5 ± 14.9 (6 months) and 64.9 ± 18.0 (2 years). The mean shoulder abduction strength improved significantly ( < .001) from 0.0 to 1.1 ± 1.4 kg (6 months) and 2.8 ± 2.6 kg (2 years). The mean AHI improved from 6.4 ± 3.3 mm to 8.0 ± 2.5 mm (6 months) and decreased to 7.1 ± 2.5 mm (2 years). This 0.7 ± 1.5-mm overall decrease was statistically significant ( = .042). At 6 months, 20 of 22 patients (90.9%) had no graft tears. At 2 years, 12 of 21 patients (57.1%) were bothered by their harvested thigh, 16 (76.2%) noticed donor site changes, 16 (76.2%) considered that the shoulder surgery's end result compensated for the thigh's changes, and 18 (85.7%) would undergo the same surgery again.
ASCR using a minimally invasive harvested fascia lata autograft produced good 6-month and 2-year shoulder outcomes in IRCTs, with low-impact thigh morbidity at 2 years.
活跃患者中伴有不可修复性肩袖撕裂(IRCT)的疼痛性功能障碍性肩部是一项挑战。关节镜下上盂唇重建术(ASCR)是一种新的治疗选择,最初描述为采用开放手术获取阔筋膜自体移植。然而,对供区并发症的担忧使外科医生不愿使用此类移植物。
采用微创获取阔筋膜自体移植的ASCR在IRCT患者中可产生良好的6个月和2年肩部疗效,且2年时大腿并发症影响较小。
病例系列;证据等级,4级。
2015年至2016年,连续22例(平均年龄64.8±8.6岁)慢性IRCT患者(滨田分级1 - 2级;古塔利耶累积分级≥3级;帕特分期1期:2例患者;帕特分期2期:6例患者;帕特分期3期:14例患者)接受了采用微创获取阔筋膜自体移植的ASCR。所有患者均完成了术前及6个月评估,包括简易肩部试验(SST)、主观肩部评分(SSV)、康斯坦特评分(CS)、活动范围(ROM)、肩峰下间隙(AHI)以及磁共振成像。21例患者完成了2年肩部及供区并发症评估。
平均主动活动范围显著改善(P <.001):抬高,从74.8°±55.5°改善至104.5°±41.9°(6个月)和143.8°±31.7°(2年);外展,从53.2°±43.3°改善至86.6°±32.9°(6个月)和120.7°±37.7°(2年);外旋,从13.2°±18.4°改善至27.0°±16.1°(6个月)和35.6°±17.3°(2年);内旋,从1.2±1.5分改善至2.6±1.5分(6个月)和3.8±1.2分(2年)。平均肩部功能评分显著改善(P <.001):SST,从2.1±2.9改善至6.8±3.5(6个月)和8.6±3.5(2年);SSV,从33.0%±17.4%改善至55.7%±25.6%(6个月)和70.0%±23.0%(2年);CS,从17.5±13.4改善至42.5±14.9(6个月)和64.9±18.0(2年)。平均肩部外展力量显著改善(P <.001),从0.0改善至1.1±1.(6个月)和2.8±2.6 kg(2年)。平均AHI从6.4±3.3 mm改善至8.0±2.5 mm(6个月),并降至7.1±2.5 mm(2年)。这0.7±1.5 mm的总体下降具有统计学意义(P =.042)。6个月时,22例患者中有20例(90.9%)未出现移植物撕裂。在2年时,21例患者中有12例(57.1%)受取阔筋膜大腿部位困扰,16例(76.2%)注意到供区变化,16例(76.2%)认为肩部手术最终结果弥补了大腿的变化,18例(85.7%)愿意再次接受相同手术。
采用微创获取阔筋膜自体移植的ASCR在IRCT患者中可产生良好的6个月和2年肩部疗效,且2年时大腿并发症影响较小。